A Reuters article reports that Johnson & Johnson has recalled four additional lots of Benadryl allergy medications and one lot of Extra Strength Tylenol gels. In following-up on its larger recall of over the counter drugs on January 15, Johnson & Johnson announced that it unintentionally failed to include the most recent medications in the previous product defects recall.
After several consumer complaints of musty or moldy odors earlier this year, Johnson & Johnson recalled 53 million bottles of a variety of products including Tylenol and Motrin painkillers, Rolaids, Benadryl and St. Joseph’s Aspirin.
With the new lots of recalled J&J medications included, the company has issued four product recalls within the last year due to quality control problems at its plants. In order to determine the reasons for these issues and to ensure that other problems are not being overlooked, a Congressional investigation has been initiated in addition to continuous examination by the U.S. Food and Drug Administration.
The Chairman of the U.S. House of Representatives Oversight and government Reform Committee, Edolphus Towns, stated, “This latest recall is further evidence that there are wide-ranging problems at Johnson & Johnson.”
While Johnson & Johnson contends that the danger of severe adverse medical events from the recalled medication is remote, consumers in possession of any of the recalled lots are advised to stop use and dispose of the medications.
Prescription and over the counter drugs are intended to alleviate an illness or condition, not create new health problems. In some cases, by the time a drug recall is announced, innocent consumers have already suffered harm as a result of the recalled medication. The California pharmaceutical litigation attorneys at Panish Shea & Boyle LLP have achieved successful case results for individuals who have been adversely affected by contaminated drugs and other consumer products. Contact us today by calling 877-800-1700 for a free consultation of your products liability case.
